Advances in ocular pharmacology.
D000818:Animals; D002188:Cannabis; D002217:Carbachol / Q000031:analogs & derivatives; D003571:Cytochalasin B / Q000494:pharmacology; D004837:Epinephrine / Q000031:analogs & derivatives; D005123:Eye / Q000187:drug effects*; D005128:Eye Diseases / Q000188:drug therapy*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D007429:Intraocular Pressure / Q000187:drug effects; D007634:Keratitis / Q000188:drug therapy; D008567:Membranes, Artificial; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D013999:Timolol / Q000627:therapeutic use; D014271:Trifluridine / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy
D008567:Membranes, Artificial; D004364:Pharmaceutical Preparations; D003571:Cytochalasin B; D013999:Timolol; D002217:Carbachol; D007372:Interferons; D014740:Vidarabine; D007065:Idoxuridine; D014271:Trifluridine; D004837:Epinephrine